LANDUZZI, LORENA
 Distribuzione geografica
Continente #
NA - Nord America 1.080
EU - Europa 420
AS - Asia 74
AF - Africa 24
SA - Sud America 7
OC - Oceania 1
Totale 1.606
Nazione #
US - Stati Uniti d'America 1.068
IT - Italia 116
DE - Germania 72
FR - Francia 69
IE - Irlanda 51
BG - Bulgaria 26
CN - Cina 25
VN - Vietnam 21
GB - Regno Unito 16
CA - Canada 12
EG - Egitto 12
FI - Finlandia 12
NL - Olanda 12
ZA - Sudafrica 11
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
SE - Svezia 8
CZ - Repubblica Ceca 7
UA - Ucraina 7
RU - Federazione Russa 6
CL - Cile 5
HK - Hong Kong 5
JP - Giappone 4
BE - Belgio 3
GR - Grecia 3
BR - Brasile 2
IN - India 2
IR - Iran 2
KR - Corea 2
SI - Slovenia 2
AU - Australia 1
DZ - Algeria 1
MO - Macao, regione amministrativa speciale della Cina 1
PK - Pakistan 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
TW - Taiwan 1
Totale 1.606
Città #
Fairfield 117
Ashburn 95
Santa Cruz 84
Seattle 63
Houston 59
Woodbridge 55
Dublin 51
Buffalo 44
Columbus 35
Bremen 34
Cambridge 32
Wilmington 32
Bologna 31
Sofia 26
Chicago 21
Ann Arbor 18
Boardman 14
Las Vegas 12
Southend 12
Rome 11
Chandler 10
Council Bluffs 10
Los Angeles 10
Ottawa 10
Dong Ket 9
Helsinki 8
Muizenberg 8
Rimini 8
Bern 7
Phoenix 7
Stockholm 7
Tappahannock 7
Cairo 6
Clearwater 6
Miami 6
New York 6
Paris 6
San Diego 6
Dallas 5
Milan 5
Shanghai 5
University Park 5
Brescia 4
Frankfurt am Main 4
Lake Forest 4
Lappeenranta 4
Parma 4
Provo 4
Riva 4
Torino 4
Amsterdam 3
Beijing 3
Büdelsdorf 3
Henderson 3
Milpitas 3
Mountain View 3
Munich 3
Naples 3
Norwalk 3
Padova 3
Ravenna 3
Wuhan 3
Atlanta 2
Auburn 2
Bellevue 2
Berlin 2
Bloomfield 2
Cedar Knolls 2
Central 2
Crocetta 2
Denver 2
Dongguan 2
Fleming Island 2
Freiburg 2
Herndon 2
Hwaseong-si 2
Leawood 2
Leverkusen 2
Providence 2
Reston 2
Ruckersville 2
Saint Petersburg 2
Saint-Quentin-Fallavier 2
San Francisco 2
San Giovanni in Persiceto 2
Silverton 2
Sunnyvale 2
Turin 2
Vicenza 2
Washington 2
Yellow Springs 2
Andover 1
Basking Ridge 1
Brookline 1
Brussels 1
Bucharest 1
Camerino 1
Central District 1
Centro 1
Changsha 1
Totale 1.138
Nome #
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations, file e1dcb333-0de2-7715-e053-1705fe0a6cc9 151
Preclinical therapy of disseminated HER-2+ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus., file e1dcb32c-2949-7715-e053-1705fe0a6cc9 119
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas., file e1dcb332-e2b7-7715-e053-1705fe0a6cc9 101
Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor, file e1dcb32c-28ee-7715-e053-1705fe0a6cc9 97
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis, file e1dcb332-6324-7715-e053-1705fe0a6cc9 96
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model, file e1dcb333-923c-7715-e053-1705fe0a6cc9 95
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug., file e1dcb330-631c-7715-e053-1705fe0a6cc9 91
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity, file e1dcb333-819d-7715-e053-1705fe0a6cc9 81
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy., file e1dcb32c-29dd-7715-e053-1705fe0a6cc9 77
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft, file e1dcb337-0581-7715-e053-1705fe0a6cc9 77
IFN-γ and CD38 in Hyperprogressive Cancer Development, file e1dcb336-8df3-7715-e053-1705fe0a6cc9 76
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R, file e1dcb332-d495-7715-e053-1705fe0a6cc9 73
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2., file e1dcb330-306b-7715-e053-1705fe0a6cc9 64
Virus-like particle display of HER2 induces potent anti-cancer responses, file e1dcb330-6126-7715-e053-1705fe0a6cc9 59
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers., file e1dcb330-859d-7715-e053-1705fe0a6cc9 59
HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy, file e1dcb337-f0cb-7715-e053-1705fe0a6cc9 51
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma, file e1dcb33a-0001-7715-e053-1705fe0a6cc9 29
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, file 60d6112b-a70b-4dc2-99bd-a748fdad85c5 27
Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug., file e1dcb332-98d8-7715-e053-1705fe0a6cc9 20
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R, file e1dcb335-33b1-7715-e053-1705fe0a6cc9 20
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma, file e1dcb339-265a-7715-e053-1705fe0a6cc9 19
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality, file 5630acdc-141c-4f7c-a4b3-db4f3187bb72 18
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression, file e1dcb338-7909-7715-e053-1705fe0a6cc9 17
Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma, file e1dcb33a-0045-7715-e053-1705fe0a6cc9 15
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine, file 205eec09-01c7-472c-80d7-400959bb2427 13
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma, file 9829c23c-a565-4fa3-87b2-566b1fa18734 12
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality, file 4d33c91d-e66d-4ece-ae99-b714c73030a9 11
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesis, file e1dcb331-3775-7715-e053-1705fe0a6cc9 11
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research, file 14f6015e-5ad1-48a8-b4f2-b6787fddbb2e 10
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality, file 4ead0436-71be-44f9-9021-f4b3c77b8576 9
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression, file cc726988-ca04-4893-af11-685d3898467b 8
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma, file ec521a88-6ad8-4a3f-b445-93d3ccff6f9a 8
IL-1 Family Members in Bone Sarcomas, file 72e2b5ee-938e-444a-be9c-bf944f821a38 6
Human responses against HER-2-positive cancer cells in human immune system-engrafted mice., file e1dcb32c-2ea4-7715-e053-1705fe0a6cc9 6
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma, file 6efa9603-ba3b-4c59-b552-a7158f73aa6b 5
Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model, file e1dcb335-1a08-7715-e053-1705fe0a6cc9 5
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas, file e1dcb32c-c4c6-7715-e053-1705fe0a6cc9 3
Evaluation of metastatic burden and recovery of human metastatic cells from a mouse model, file e1dcb32d-bd84-7715-e053-1705fe0a6cc9 3
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response, file e1dcb330-0111-7715-e053-1705fe0a6cc9 3
Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma, file bba60d03-2329-4e3b-99a6-df6ca9635362 2
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine, file d81481ab-2bbf-4db2-a07a-f00796d21ae3 2
Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice., file e1dcb330-8a9d-7715-e053-1705fe0a6cc9 2
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma, file e1dcb336-dfe9-7715-e053-1705fe0a6cc9 2
Targeting CD99 compromises the oncogenic effects of the chimera EWS-FLI1 by inducing re-expression of zyxin and inhibition of Gli1 activity, file e1dcb338-e476-7715-e053-1705fe0a6cc9 2
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC, file 03b199ed-feb0-47f3-883c-ac51c7e13567 1
Virus-like particle display of HER2 induces potent anti-cancer responses, file e1dcb338-8575-7715-e053-1705fe0a6cc9 1
Totale 1.657
Categoria #
all - tutte 5.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 0 0 3
2019/2020263 3 3 0 13 26 31 32 35 42 32 23 23
2020/2021269 22 25 14 21 14 19 25 18 23 22 39 27
2021/2022350 16 20 22 17 32 11 16 26 16 13 112 49
2022/2023418 11 15 92 82 23 16 14 18 61 15 61 10
2023/2024350 21 11 26 28 37 67 31 32 27 20 50 0
Totale 1.657